Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2018 May;59(5):1048-1061.
doi: 10.1111/epi.14073. Epub 2018 Apr 16.

The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): A randomized controlled trial

Affiliations
Randomized Controlled Trial

The effectiveness of a group self-management education course for adults with poorly controlled epilepsy, SMILE (UK): A randomized controlled trial

Leone Ridsdale et al. Epilepsia. 2018 May.

Abstract

Objective: Epilepsy is one of the most common neurological conditions affecting about 1% of adults. Up to 40% of people with epilepsy (PWE) report recurring seizures while on medication. And optimal functioning requires good self-management. Our objective was to evaluate a group self-management education courses for people with epilepsy and drug-resistant seizures by means of a multicenter, pragmatic, parallel group, randomized controlled trial.

Methods: We recruited adults with epilepsy, having ≥2 seizures in the prior 12 months, from specialist clinics. Consenting participants were randomized 1:1 to a group course or treatment as usual. The primary outcome measure was quality of life 12 months after randomization using Quality of Life 31-P (QOLIE-31-P). Secondary outcome measures were seizure frequency and recency, psychological distress, impact and stigma of epilepsy, self-mastery, medication adherence, and adverse effects. Analysis of outcomes followed the intention-to-treat principle using mixed-effects regression models.

Results: We enrolled 404 participants (intervention: n = 205, control: n = 199) with 331 (82%) completing 12-month follow-up (intervention: n = 163, control: n = 168). Mean age was 41.7 years, ranging from 16 to 85, 54% were female and 75% were white. From the intervention arm, 73.7% attended all or some of the course. At 12-month follow-up, there were no statistically significant differences between trial arms in QOLIE-31-P (intervention mean: 67.4, standard deviation [SD]: 13.5; control mean: 69.5, SD 14.8) or in secondary outcome measures.

Significance: This is the first pragmatic trial of group education for people with poorly controlled epilepsy. Recruitment, course attendance, and follow-up rates were higher than expected. The results show that the primary outcome and quality of life did not differ between the trial arms after 12 months. We found a high prevalence of felt-stigma and psychological distress in this group of people with drug-resistant seizures. To address this, social and psychological interventions require evaluation, and may be necessary before or alongside self-management-education courses.

Keywords: education; epilepsy; quality of life; randomized controlled trial; self-management.

PubMed Disclaimer

Figures

Figure 1
Figure 1
CONSORT diagram of participant recruitment and retention in the trial. Recruitment occurred through 3 stages, the first 2 requiring patients to opt out in order to not progress through the pathway. The third stage involved researchers contacting patients who did not opt out at stages 1 and 2. Three participants who consented were not randomized, in error. At the 6‐month follow‐up, missing outcome data occurred due to participants either not wanting to continue and formally withdrawing (n = 23 intervention; n = 15 TAU) or being presumed lost to follow‐up, that is, not returning postal questionnaires and being unreachable. Some of these participants who were presumed lost to follow‐up remained in the study and later participated in the 12‐month follow‐up. All participants not completing outcome data at the 12‐month follow‐up were considered withdrawals (n = 19 intervention; n = 16 TAU), that is, this included participants not wanting to continue and those lost‐to‐follow‐up

Comment in

References

    1. Ridsdale L, Charlton J, Ashworth M, et al. Epilepsy mortality and risk factors for death in epilepsy: a population‐based study. Br J Gen Pract. 2011;61:e271–8. - PMC - PubMed
    1. Moran NF, Poole K, Bell G, et al. Epilepsy in the United Kingdom: seizure frequency and severity, anti‐epileptic drug utilization and impact on life in 1652 people with epilepsy. Seizure. 2004;13:425–33. - PubMed
    1. Thapar A, Kerr M, Harold G. Stress, anxiety, depression, and epilepsy: investigating the relationship between psychological factors and seizures. Epilepsy Behav. 2009;14:134–40. - PubMed
    1. Ettinger AB, Good MB, Manjunath R, et al. The relationship of depression to antiepileptic drug adherence and quality of life in epilepsy. Epilepsy Behav. 2014;36:138–43. - PubMed
    1. Ridsdale L. Avoiding premature death in epilepsy. BMJ. 2015;350:h718. - PubMed

Publication types

LinkOut - more resources